Long-Term Functional Stability of Functional Nucleic Acid- Gold

17 hours ago - Thiolated functional nucleic acid-gold nanoparticle conjugates (FNA-AuNPs) are the core recognition elements in biosensors. The long-te...
0 downloads 0 Views 1MB Size
Journal Pre-proof Target lipidomics approach to reveal the resolution of inflammation induced by Chinese medicine combination in Liu-Shen-Wan against realgar overexposure to rats Jiaojiao Wang, Lanfang Ding, Jing Zhou, Hongyue Ma, Yuanyuan Wu, Jiajia Wang, Xiang Lv, Shengjin Liu, Hengbin Wang, Yanqing Yan, Niancui Luo, Quan Li, Huiqin Xu, Liuqing Di, Qinan Wu, Jinao Duan PII:

S0378-8741(19)31587-9

DOI:

https://doi.org/10.1016/j.jep.2019.112171

Reference:

JEP 112171

To appear in:

Journal of Ethnopharmacology

Received Date: 20 April 2019 Revised Date:

20 July 2019

Accepted Date: 18 August 2019

Please cite this article as: Wang, J., Ding, L., Zhou, J., Ma, H., Wu, Y., Wang, J., Lv, X., Liu, S., Wang, H., Yan, Y., Luo, N., Li, Q., Xu, H., Di, L., Wu, Q., Duan, J., Target lipidomics approach to reveal the resolution of inflammation induced by Chinese medicine combination in Liu-Shen-Wan against realgar overexposure to rats, Journal of Ethnopharmacology (2019), doi: https://doi.org/10.1016/ j.jep.2019.112171. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Published by Elsevier B.V.

1

Target lipidomics approach to reveal the resolution of inflammation

2

induced by Chinese medicine combination in Liu-Shen-Wan against

3

realgar overexposure to rats

4 5

Jiaojiao Wanga,#, Lanfang Dingc,#, Jing Zhoua,*, Hongyue Maa,*, Yuanyuan Wua, Jiajia Wanga,

6

Xiang Lva, Shengjin Liua, Hengbin Wangd, Yanqing Yand, Niancui Luod, Quan Lid, Huiqin Xua,

7

Liuqing Dib, Qinan Wua, Jinao Duana

8

a. Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources

9

Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM

10

Formulae, and Jiangsu Key Laboratory of efficacy and safety evaluation of TCM,

11

Nanjing University of Chinese Medicine, Nanjing, China.

12

b. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China; Jiangsu

13

Provincial TCM Engineering Technology Research Center of Highly Efficient Drug

14

Delivery System (DDS), Nanjing, China.

15

c. Nanjing Maternity and Child Health Care Hospital, Nanjing, China.

16

d. Leiyunshang Pharmaceutical Company. Ltd, Suzhou , China.

17

#

Jiaojiao Wang and Lanfang Ding have equal contribution to this paper

18 19

* Corresponding author:

20

Jing Zhou

21

Email: [email protected]

22

Address: No.138 xianlin avenue, qixia district, nanjing city, jiangsu province

23

Phone Number: +86 13645180005

24 25

Hongyue Ma

26

Email: [email protected]

27 28

Author Contributions: 1

29

writing—original draft preparation, Jiaojiao Wang and Lanfang Ding;

30

methodology, Jing Zhou and Hongyue Ma;

31

formal analysis, Yuanyuan Wu, Jiajia Wang, Xiang Lv and Shengjin Liu;

32

writing—review and editing, Jing Zhou and Hongyue Ma;

33

project administration, Hengbin Wang, Yanqing Yan, Niancui Luo and Quan Li;

34

funding acquisition, Huiqin Xu, Liuqing Di, Qinan Wu and Jinao Duan.

35 36

[email protected]

37

[email protected]

38

[email protected]

39

[email protected]

40

[email protected]

41

[email protected]

42

lyxhj09@ 163.com

43

[email protected]

44

[email protected]

45

[email protected]

46

[email protected]

2

47

Abstract

48

Ethnopharmacological relevance: Liu-Shen-Wan (LSW) is one of the popular

49

over-the-counter drugs in Asia, which contains realgar (As4S4), used for the treatment

50

of upper respiratory tract inflammation and skin infections. However, the safety and

51

potential risk of this arsenic remain unknown.

52

Aim of the study: The aim of this study was to determine total arsenic in tissue and

53

investigate effects of regular dose and overdose LSW exposure on rat liver.

54

Materials and methods: We used a target lipidomics approach to quantify

55

inflammatory eicosanoids and employed ICP-MS to determine total arsenic in tissue.

56

Results: The results showed that oral administration of 8 and 40 mg/kg LSW (1 and 5

57

fold human-equivalent dose) induced light changes of liver lipidomic profile in rats,

58

which was associated with anti-inflammatory function of LSW. In our recent report,

59

we observed that 41 and 134 mg/kg realgar (40 and 132 fold human-equivalent dose)

60

stimulated rat liver inflammation through up-regulation of pro-inflammatory

61

LOX-derived, CYP-derived HETEs and COX-derived PGs. However, we found that

62

LSW in the form of drug combination, containing 41 and 134 mg/kg realger, could

63

not stimulate these similar inflammatory responses in rats, although the liver total

64

arsenic levels of the realger and LSW groups were same.

65

Conclusion: The downregulation of pro-inflammatory showed that the LSW

66

containing realger is safer than realger alone administrated to rats. These results

67

suggested that Chinese medicines combination could reduce realgar-derived arsenic

68

toxicity in rats.

69 70

Key words: Liu Shen Wan; Liver inflammation; Realgar; Reducing toxicity; Chinese

71

medicine compatibility.

72 73

Abbreviations: LSW, Liu-Shen-Wan; ICP-MS, Inductively coupled plasma mass

74

spectrometry; APL, Acute promyelocytic leukemia; TCM, Traditional Chinese 3

75

medicines; COX, Cyclooxygenases; LOX, Lipoxygenases; CYP, Cytochrome P450;

76

HPLC, High Purity Liquid Chromatography; ISs, internal standards; CMC-Na,

77

Carboxymethyl Cellulose Sodium; ALT, lanine aminotransferase; ALB, albumin;

78

AST, aspartate aminotransferase; TP, total protein; TBIL, total bilirubin; ALP,

79

alkaline phosphatase; GLU, glucose; BUN, blood urea nitrogen; CREA, creatinine;

80

CHOL, total cholesterol; LDH, lactate dehydrogenase; TG, Triglyceride; CK, creatine

81

kinase; K, potassium; Na, sodium; Cl, chlorine; NHJDP, Niu-Huang-Jie-Du-Pian;

82

OPLS-DA, orthogonal projections to latent structures discriminant analysis; DHA,

83

docosahexaenoic acid; AA, Arachidonic Acid; As2O3, arsenic trioxide; NaAsO2,

84

sodium arsenite; Na2HAsO4, arsenate;

85 86

Introduction

87

Traditional medicines have gained ever-increasing popularity due to its

88

therapeutic effects on many diseases and their natural compounds present as strong

89

candidates for the treatment of cancer pain recently. Realgar (As4S4), referred to as

90

“Xionghuang”, is one of the traditional mineral medicines in China and as an

91

arsenical, and it is known as a poison and paradoxically as a therapeutic agent in small

92

doses for the treatment of tonsillitis, herpes zoster, sore throat and convulsions(Liu et

93

al., 2013). There are about 440 Chinese medicine preparations in use and about 78

94

that contain realgar(Lu et al., 2011). Realgar is the essential component of some

95

popular medicinal preparations in Asian and Western countries, used as the oral

96

formulation in the treatment of both newly and relapsed/refractory diagnosed acute

97

promyelocytic leukemia (APL) currently (Qi et al., 2010). However, chronic exposure

98

to realgar also induced potential toxicological risk, produce toxicity to the livers and

99

kidneys and cause other arsenic-related diseases because of the highly toxic substance,

100

arsenic (Wei et al., 2009). Research showed that the liver was the major target organ

101

of arsenic exposure. It has been reported that arsenic trioxide exposure brought about

102

the IL-6 mediated inflammatory response, oxidative stress, significantly elevation in 4

103

activity of liver enzymes and cellular necrosis in rat livers(Li et al., 2016) recently and

104

sometimes led to liver injury . Thus, the arsenic-containing traditional medicines are

105

commonly used in clinic treatment and that might bring the risk due to its wide

106

exposure.

107

It is a traditional concept that Chinese medicine compatibility can attenuate the

108

risk of toxic Traditional Chinese medicines. Realgar used to combined with some

109

other herbal medicines to reduce toxicity and side effect or improve the efficacy in

110

TCMs and Indian Ayurveda medicines. Liu-Shen-Wan (LSW) is one of these

111

common medicines, containing realgar (Arsenic sulfide), bezoar (Bos taurus

112

domesticus Gmelin), borneol (Dryobalanops aromatica Gaertner. f.), Musk (Moschus

113

berezovskii Flerov), toad venom (Bufo bufo gargarizans Cantor)and pearl (Pteria

114

martensii (Dunker), for the treatment of upper respiratory inflammation . It has been

115

known that the toxicity of realgar was far lower than inorganic arsenite (toxic As(III)

116

and As(V)) based on their LD50 in mice (Liu et al., 2008), and we have found that oral

117

administration of the pure realgar at maximal dosage could not cause the death of

118

mice previously. We assumed that the toxicology risk of realgar was different from its

119

preparations in the form of herbal combination, and actions have been taken to

120

evaluate whether the compatibility with other Chinese medicines can reduce the

121

realgar poisonousness. Several studies showed that the classic toxicological methods of

122

investigating arsenic toxicity and its mechanisms in experimental animals are

123

insufficient and of limitations, and cannot make early predictions of liver damage

124

(Kitchin and Conolly, 2010). So the new research techniques or approaches are

125

needed for the prediction of realgar toxicity. Lipidomics had been employed in

126

biological samples for the comprehensive analysis and characterization of the

127

metabolism of lipids at the molecular level and showed great possibilities to identify

128

early related biomarkers in liver injury and other inflammatory diseases recently (Tam

129

et al., 2013; Xie et al., 2016). The content of endogenous metabolites, such us

130

eicosanoids, could precede the development of clinical liver injury and the 5

131

phospholipid markers had higher sensitivity than conventional pharmacological

132

indicators(Rolim et al., 2015). Currently, eicosanoids had been monitored in rat serum

133

after orally administration with a single dose of NaAsO2 and were proved to reflect

134

sensitively acute arsenic toxicity (Chen et al., 2017). Arachidonic acid (AA),an

135

important inflammatory lipid mediator,can regulate liver mitochondria oxidative

136

stress by the cyclooxygenase (COX),lipoxygenase (LOX) and cytochrome P450

137

(CYP450) metabolic pathways. Eicosanoids and its metabolites have certain

138

physiological activities and their epoxidase metabolism, named prostaglandins, are

139

known as inflammatory factors in the body, while lipoxygenase metabolite is regarded

140

as anti-inflammatory ingredients mostly(O'Connell and Watkins, 2010). Thus, it

141

makes sense to monitor some characteristic phospholipid markers to make a more

142

comprehensive understanding of realgar toxicity in the rats.

143

Our recent study showed that realgar at 40 and 132 fold human-equivalent doses

144

significantly induced the liver inflammation in rats through up-regulation of

145

COX-derived mediators (Zhou et al., 2019). However, the safety of Liu-Shen-Wan

146

containing realgar has not been elucidated. In this paper, we use lipidomics combined

147

with the routine testing to evaluate effects of regular dose and overdose LSW on

148

livers in rats. Moreover, we compared toxicity of realgar alone and in combination

149

with other herbal medicines (Liu-Shen-Wan), getting comprehensive understanding of

150

safety and drug risks of LSW.

151 152

Materials and Methods

153

Reagents and samples

154

Liu-Shen-Wan (LSW, batch number Z32020481) and realgar (As4S4, purity:

155

94.5%) were obtained from Leiyunshang Pharmaceutical Company. Ltd (Suzhou,

156

China), which was prepared by mixing Xionghuang, Niu-huang, She-xiang, Chan-shu,

157

Zhen-zhu, etc. The contents of ten representative compounds in LSW analyzed by

158

HPLC method were as follows: gamabufotalin, 0.91 mg/g; arenobufagin, 0.51 mg/g; 6

159

telocinobufagin, 1.51 mg/g; bufotalin, 1.63 mg/g; cinobufotalin, 2.50 mg/g; bufalin,

160

1.87 mg/g; resibufogenin, 1.89 mg/g; cinobufagin, 4.46 mg/g; cholic acid, 25.1 mg/g;

161

bilirubin,

162

CAS-No.67-56-1, batch number AS1922), acetonitrile (HPLC-grade, CAS-No.

163

75-05-8,

164

CAS-No.67-63-0) were purchased from Tedia (Fairfield, Ohio, USA). The

165

deuterium-labeled internal standards (ISs) AA-d8 (batch number 20150513) were

166

gained from Cayman Chemical (Ann Arbor, MI, USA). Other reagent solutions,

167

including formic acid (HPLC-grade, batch number F0507), were obtained from

168

Sigma-Aldrich Corp (Louis, MO, USA). The lipid standards (batch number

169

15090801), PGF2ɑ was from SantaCruz and the standard substances, 15-HETrE,

170

9,10-diHOME, 15-HETE, 13-HODE, 17,18 EpETE, 10-HDoHE, 9,10 EpOME, 19,20

171

EpDPA and arachidonic acid were all from Cayman.

1.58

batch

mg/g

(Supplementary

number

AS1122)

Figure

and

1).

isopropyl

Methanol

alcohol

(HPLC-grade,

(HPLC-grade,

172 173

Animal

174

Fifty healthy male Sprague-Dawley rats weighing 85-95 g used in the study were

175

obtained from the Experimental Animal Center of Zhejiang (animal certificate

176

number SCXK-zhe-2014-0001). Male animals were housed in standardized

177

animal-house at a stable temperature (23±3 °C) and humidity (60±5%) under

178

continuous observation. They were allowed free access to a commercial standard diet

179

and water ad libitum. Animal experiments were performed in accordance with Guide

180

for the Care and Use of Laboratory Animals (National Research Council of USA,

181

1996) and related ethical regulations of Nanjing University of Chinese Medicine.

182 183

Experimental design

184

The preparation LSW samples were dissolved in newly prepared 0.5% CMC-Na

185

(Carboxymethyl Cellulose Sodium) solution to obtain different concentrations of

186

suspending solutions. Rats were divided into six groups randomly. Group 1 (Nor 1) 7

187

received 0.5% CMC-Na as control for one month; group 2 (LL-p) received 8 mg/kg

188

Liu-Shen-Wan for one month; group 3 (LH-p) received 40 mg/kg Liu-Shen-Wan for

189

one month; group 4 (Nor 2) received 0.5% CMC-Na as control for two months; group

190

5 (LL) received 320 mg/kg Liu-Shen-Wan for two months; group 6 (LH) received

191

1000 mg/kg Liu-Shen-Wan for two months. The corresponding drugs were

192

administered via the oral route one time per day. The body weights and food intakes

193

of rats were recorded every day. After 1 or 2 months oral administration, rats were

194

euthanized. Blood examples were collected from abdominal aorta and the isolated

195

serum is stored in a cryogenic refrigerator for biochemical assays. Rat liver tissue

196

were isolated, snap-frozen ( with nitrogen) and stored at -80 °C for later testing.

197 198

Determination of total arsenic

199

The liver samples (0.025g) were spiked into 2 ml concentrated HNO3 and placed

200

in a fume hood standing overnight. After being digested at 150 °C for 1 h, 2 ml H2O2

201

and an additional 1 ml HNO3 was added to the samples, and heated until they had

202

boiled dry. Samples were diluted to a final mass of 4 g with 1% (v/v) HNO3. Then we

203

apply ICP-MS analysis of liver digests to determine the total arsenic under instrument

204

conditions described elsewhere (Nearing et al., 2014) and using indium as an internal

205

standard introduced via a separate sample line. Besides, certified ICP standards were

206

used for calibration.

207 208

Liver function tests

209

Blood samples were centrifuged at 2000 rpm for 15 min and supernatant were

210

collected as serum. The indicators for liver injury — alanine aminotransferase (ALT),

211

aspartate aminotransferase (AST), total protein (TP), albumin (ALB), total bilirubin

212

(TBIL), alkaline phosphatase (ALP), glucose (GLU), blood urea nitrogen (BUN),

213

creatinine (CREA), total cholesterol (CHOL), lactate dehydrogenase (LDH),

214

triglyceride (TG), creatine kinase (CK), electrolytes potassium (K), sodium (Na) and 8

215

chlorine (Cl) — were assayed using standard commercial kits and automatic

216

biochemical analyzer (HITACHI 7100, Japan).

217 218

Liver histopathology examination

219

Liver of rats was selected and fixed with 10% neutral formalin solution. Then

220

samples were embed with conventional paraffin-embedding protocol and sliced into 4

221

μm thickness tissues. The slides were stained with hematoxylin and eosin and

222

observed under an optical microscope to evaluate the histopathological injury.

223 224

Analysis of lipidomics in livers using UPLC-MS/MS

225

Randomly sample some frozen liver tissue, add 0.9% normal saline to cool liver

226

tissue in a homogenizer and homogenate 5min on the ice. Then separate mediators

227

from livers with the liquid-liquid extraction. 4 ml ethyl acetate and n-hexane

228

(vol/vol=1:1, cooled to -80 °C) were added to the 4.0 ml of 10% liver homogenate,

229

along with the 25ul chloramphenicol methanol solution (1ug/ml). After vortex mixing,

230

the sample was ultra-sonicated at 100 Hz for 20 min in the ice water bath (KQ3200,

231

Kunshan, Jiangsu) centrifuged at 2000 r/min for 5 min and stood at 4 °C for 5 min.

232

Then transfer the supernatants to a fresh tube and the procedures were repeated until

233

the supernatants were completely obtained. Next, combine organic phase in a 10ml

234

centrifuge tube, swirl and volatilize at 37 °C. Centrifuge, dried the supernatants and

235

re-constitute the residue with 500 µl of 90% acetonitrile solution for UPLC-MS/MS

236

analysis.

237

Chromatography was performed on a Synergi reverse-phase C18 column (50×2

238

mm, USA, Phenomenex) using an UPLC system (SHIMADZU LC-20AD XR). The

239

flow rate was 0.30 ml/min and the column was maintained at 35 °C. The mobile phase

240

A was composed of water, acetonitrile and formic acid (water–acetonitrile–formic

241

acid= 70:30:0.02, v/v/v). The mobile phase B was composed of acetonitrile and

242

isopropyl alcohol (acetonitrile–isopropyl alcohol= 50:50, v/v). The column was eluted 9

243

with a linear gradient system: 0–3 min, 0–25% B; 3–11 min, 25–45% B; 11–13 min,

244

45–60% B; 13–18 min, 60–75% B; 18–18.5 min, 90% B; 18.5–20 min, 90% B; 20-21

245

min, 0%; 21-25 min, 0%. The injected sample was 5 µl. The UPLC was directly

246

interfaced with an AB Sciex QTRAP 5500 system (AB SCIEX, Foster City, CA,

247

USA) spectrometer with an ESI source operated in the negative ion mode. Set

248

parameters in the source as follows: ion spray voltage was -4500 V; turbo ion spray

249

temperature was 525 °C; curtain gas was 10 psi; nebulizer gas (GS 1) was 30 psi;

250

heater gas (GS 2) was 30 psi; dwell time was 50 ms. Data were collected in multiple

251

reaction monitoring (MRM) mode by screening parent and daughter ions. The internal

252

standard, AA-d8, was used for the quality control. The data of all eicosanoids content

253

were transferred to SIMCA-P for the principal component analysis (PCA).

254 255

Identification and selection of the clinic literatures

256

To evaluate the adverse effects of realgar-containing preparations and arsenic

257

trioxide in patients, the clinic literatures were collected. The evidence for adverse

258

reactions is consisted of short-term toxicity ( 1

259

month). Relevant literature reporting results of this kind of studies was identified by

260

means of a computerized search of multiple electronic bibliographic databases

261

(PUBMED, CNKI.NET, NCBI, WanFang Date and OvidSP). Using the terms

262

appropriated to each database, the search strategy composed by the adverse reactions

263

of realgar-containing preparations and arsenic, and comparison to results was made.

264

Besides, two reviewers independently screened the eligibility of the articles first on

265

the title and the abstract, and then on the full text.

266 267

Statistics

268

The results were expressed as mean ± SD and statistical analysis was performed

269

using two-tailed unpaired Student’s t-test. A P value of less than 0.05 was considered

10

270

statistically significant and P less than 0.01 was deemed outstanding statistically

271

significant.

272 273

RESULTS

274

Comparison of adverse clinical reactions of two realgar-containing preparations

275

Table 1 has summarized the common adverse clinical outcomes of two

276

realgar-containing preparations (Liu-Shen-Wan, LSW, and Niu-Huang-Jie-Du-Pian,

277

NHJDP) and the arsenic trioxide injection. For the short-term toxicity ( 1 month), LSW induced liver inflammation

281

and other clinical symptoms in about 2.6% case numbers. However, the NHJDP or

282

arsenic trioxide injection seemed to be more toxic on liver than LSW with liver

283

damage induction rate of 11.5% and 7.9%, respectively. Besides, the NHJDP caused

284

the chronic arsenism (13.5%, 7/52). In summary, the LSW had lower adverse clinical

285

reactions on livers than realgar and another realgar-containing preparations (NHJDP).

286 287

Total arsenic content in rat livers

288

In this experimental study, we firstly determined total arsenic content in rat livers.

289

The oral administration of 8 and 40 mg/kg LSW (1 and 5 fold human equivalent doses)

290

for one month significantly increased the total arsenic contents of livers from the

291

0.83±0.11 µg/g in the normal control to 2.24±0.55 µg/g and 3.56±0.66 µg/g,

292

respectively (Figure 1). LSW overexposure (320 and 1000 mg/kg LSW, 40 and 132

293

fold human equivalent doses) to rats for two months could elevate the total arsenic

294

contents in livers from 1.03±0.21 µg/g in the normal control to 31.73±10.24 µg/g and

295

32.6±4.67 µg, respectively (Figure 1). Here, we noticed that the oral administration of

296

41 and 134 mg/kg realgar (equivalent to 320 and 1000 mg/kg LSW) for two months

297

had the similar total arsenic (30.28±14.73 µg/g and 31.15±5.64 µg/g (our data 11

298

published (Zhou et al., 2019)) as the LSW. This illustrated that total arsenic intakes of

299

rats exposed to the realgar alone and its TCM preparation were the same, and

300

LSW in the form of herbal combination did not reduce the total arsenic content in

301

realgar-treated rats.

302 303

Effects of LSW exposure on the biochemical markers

304

As shown in figure 2, compared with the normal control groups, the weight and

305

the amount of food intake in rats orally administrated of LSW had no marked change

306

(P > 0.05). That indicated LSW had no significant effects on the growth and

307

development of rats.

308

Then, we evaluated the function of rat liver and biochemical markers treated with

309

LSW. It showed that serum enzyme activity did not have significant changes,

310

including ALT, AST, TBIL, ALP, ALB, LDH, GLU, TP et al. (Table 2). There was

311

slight fluctuation in individual index, but no statistical significant differences between

312

treated and normal groups were observed (P > 0.05) generally. Meanwhile, the results

313

of liver histopathology examination showed the same evidence, presenting no cell

314

necrosis, interstitial vasodilation, congestion, abnormalities and histological changes

315

in rats after exposure to LSW (figure 3). These evidences illustrated that oral

316

administration of regular dose and overdose LSW for one or two months did not cause

317

liver injuries in rats.

318 319

Intervention of herbal combination in LSW on lipid markers

320

To investigate the effects of different doses LSW, the supervised method,

321

orthogonal projections to latent structures discriminant analysis (OPLS-DA), was

322

used to separate predictive variables responsible for the inter-group differences (figure

323

4A). The fold changes (FC) in content which are more than 1.5 were selected as

324

biomarkers and the significant markers (P